Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo

NCT03097861 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

552

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Idiopathic Constipation

Interventions

DRUG: Lubiprostone
DRUG: Placebo

Sponsor

Sucampo Pharma Americas, LLC

Collaborators

[object Object]
[object Object]